CISD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.023000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.777600E-01
Normal-vs-Stage2
3.252800E-01
Normal-vs-Stage3
8.467000E-01
Normal-vs-Stage4
2.290200E-01
Stage1-vs-Stage2
8.557000E-01
Stage1-vs-Stage3
3.643000E-01
Stage1-vs-Stage4
6.395000E-01
Stage2-vs-Stage3
3.867800E-01
Stage2-vs-Stage4
5.075600E-01
Stage3-vs-Stage4
2.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.199800E-01
Normal-vs-AfricanAmerican
1.622200E-01
Normal-vs-Asian
4.267800E-01
Caucasian-vs-AfricanAmerican
6.417600E-01
Caucasian-vs-Asian
5.919600E-01
AfricanAmerican-vs-Asian
3.610000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.789000E-01
Normal-vs-Female
2.134000E-01
Male-vs-Female
4.852200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.706200E-01
Normal-vs-Age(41-60Yrs)
1.565360E-01
Normal-vs-Age(61-80Yrs)
4.075000E-01
Normal-vs-Age(81-100Yrs)
3.520000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.775200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.822400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.083200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.164100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.529600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.185800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.666400E-01
Normal-vs-Daily Drinker
4.509000E-01
Normal-vs-Weekly Drinker
5.409800E-01
Normal-vs-Occasional Drinker
1.416560E-01
Normal-vs-Social Drinker
3.915600E-01
Non Drinker-vs-Daily Drinker
7.608800E-01
Non Drinker-vs-Weekly Drinker
6.871200E-01
Non Drinker-vs-Occasional Drinker
1.528420E-02
Non Drinker-vs-Social Drinker
5.374000E-01
Daily Drinker-vs-Weekly Drinker
5.440800E-01
Daily Drinker-vs-Occasional Drinker
5.723700E-02
Daily Drinker-vs-Social Drinker
7.627600E-01
Weekly Drinker-vs-Occasional Drinker
1.703560E-02
Weekly Drinker-vs-Social Drinker
3.886600E-01
Occasional Drinker-vs-Social Drinker
1.549810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.984000E-01
Normal-vs-Grade 2
7.217600E-01
Normal-vs-Grade 3
2.771200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.179400E-01
Grade 1-vs-Grade 3
7.426000E-01
Grade 1-vs-Grade 4
3.984000E-01
Grade 2-vs-Grade 3
6.177600E-01
Grade 2-vs-Grade 4
7.217600E-01
Grade 3-vs-Grade 4
2.771200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.759400E-01
Normal-vs-NonDiabetic
2.613000E-01
Diabetic-vs-NonDiabetic
5.005500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.315200E-01
Normal-vs-NoPancreatitis
3.501200E-01
Pancreatitis-vs-NoPancreatitis
7.675800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.733600E-01
Normal-vs-N1
3.219000E-01
N0-vs-N1
6.415400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.773250E-01
Normal-vs-TP53-NonMutant
6.113000E-01
TP53-Mutant-vs-TP53-NonMutant
1.027850E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
